SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001457612-19-000025
Filing Date
2019-02-28
Accepted
2019-02-28 08:07:19
Documents
6
Period of Report
2019-02-28
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K gncafy2018ye8k.htm 8-K 28815
2 EXHIBIT 99.1 exhibit991gncaq4resultsp.htm EX-99.1 14000
3 exhibit991gncaq4resultsp001.jpg GRAPHIC 146698
4 exhibit991gncaq4resultsp002.jpg GRAPHIC 219095
5 exhibit991gncaq4resultsp003.jpg GRAPHIC 149644
6 exhibit991gncaq4resultsp004.jpg GRAPHIC 128503
  Complete submission text file 0001457612-19-000025.txt   931395
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36289 | Film No.: 19640512
SIC: 2836 Biological Products, (No Diagnostic Substances)